GLP-1 RAs are increasingly used in the treatment of T2DM due to their multifaceted benefits, including improving glycemic control, reducing body weight, enhancing -cell function, and yielding favorable cardiovascular and renal outcomes [22]
In a mid-stage trial, nearly three-quarters of patients experienced nausea, nearly half experienced vomiting, and an much as a quarter experienced diarrhea numbers the company considered too high to convince people to take its drug twice every day
Diabetes 19934216781682
Theyre not magic pills, but tools that can help you reach your health goals
Aim for 150 minutes of exercise each week
Hims & Hers said Wednesday that it will begin offering GLP-1 microdosing treatments, doubling down on selling copycat versions of the blockbuster weight-loss drugs made by Novo Nordisk